Chronic Neuropathy Following Chemotherapy
CompletedNCT02654691
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a clinical study which is a follow-up of a previous prospective questionnaire study. All patients who previously participated in the study will receive a new questionnaire and will be invited for a clinical examination.
Study details
- Official title
- DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Chronic Neuropathy Following Chemotherapy
- Conditions
- Peripheral Nervous System Diseases
- Chronic Pain
- Sponsor
- Danish Pain Research Center
- Collaborators
- University of Oxford; Imperial College London; University of Dundee; Mentis Cura; Institut National de la Santé Et de la Recherche Médicale, France; University of Kiel; Lund University; Technion, Israel Institute of Technology; University Ghent; Neuroscience Technologies S.L.P
- Start date
- 2016-06
- Primary completion
- 2017-04
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Denmark
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * all patients who have participated in a prospective questionnaire study Exclusion Criteria: * Not able to visit in person.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02654691